- You can view the full Incyte Ratings Report.
- Use our drugs section to find industry-relevant news.
- Or find some new ideas from our top rated stocks lists.
- Find other investment ideas from our top rated ETFs lists.
UnitedHealth becomes the second major healthcare provider to scratch the insulin product from its 2017 medicines roster.
Cramer says he liked Yelp's quarter and is staying away from Cheniere Energy.
Cramer finds the good and the bad in the continued oil glut.
Pfizer (PFE) has agreed to acquire Medivation (MDVN) for $14 billion, fueling speculation of a future deal with Incyte (INCY).